psilocybin
A recent pilot study published in the Journal of Psychedelic Studies has found preliminary evidence that psilocybin, when administered in a group retreat setting, can enhance psychological flexibility. The findings suggest that changes in psychological flexibility may play a crucial role in the therapeutic benefits of psilocybin experiences. Psilocybin is a naturally occurring psychedelic compound found in over 200 species of mushrooms, known colloquially as “magic mushrooms.” When ingested, psilocybin is converted into psilocin in the body, which then influences serotonin receptors in the bra...
PsyPost
Recent scientific advancements have shed light on the potential synergistic effects of meditation and psychedelic substances. A study published in Scientific Reports reveals how psilocybin, a psychedelic compound, when combined with open monitoring meditation may enhance the depth of insightfulness in experienced meditators. This enhancement appears to be mediated by changes in the brain’s organizational patterns. Open monitoring meditation is a type of meditation that emphasizes the broad, non-reactive awareness of the content of experience from moment to moment. Unlike focused attention medi...
PsyPost
Psilocybin, a psychedelic compound found in “magic mushrooms,” has shown promise in the treatment of mental health conditions. However, the substances is also known to induce acute anxiety. New research published in iScience00908-8) sheds light on the biological underpinnings of this anxiety, suggesting it stems from different brain processes than those driving the psychedelic effects. “While many scientific studies are currently looking into how psychedelics in general, and psilocybin in particular, may be used clinically to reduce depression and anxiety in the long term, only a handful of st...
PsyPost
In recent years, interest in psychedelic-assisted therapy has grown due to its potential to treat various psychological disorders such as depression, anxiety, and post-traumatic stress disorder. However, a new study published in the Journal of Psychedelic Studies raises important concerns. It suggests that while there may be benefits, there are also significant risks. The study focuses on the negative effects reported by therapists who facilitate such treatments, highlighting that the impacts of psilocybin are not universally beneficial and can vary widely from one individual to another. Psilo...
PsyPost
Scientists have recently discovered that psilocybin, the active ingredient in “magic mushrooms,” can significantly reduce chronic pain in rats. Notably, this pain relief was related to pain from touch, but not pain from heat. The study was published in Current Biology01374-X). Psychedelic drugs have recently gained attention for their potential to treat various psychiatric disorders. Psilocybin, in particular, has been the subject of research for its therapeutic effects on treatment-resistant depression as well as alcohol and tobacco abuse. Led by Nicholas Kolbman, researchers from the Univers...
PsyPost
Scientists have started to investigate whether a compound found in magic mushrooms, psilocybin, could play a role in combating the effects of diabetes. According to their preliminary research, published in the journal Genes, psilocybin might help prevent the loss of critical insulin-producing cells in the pancreas. Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms. In recent years, its therapeutic potential has begun to be recognized, particularly for mental health conditions. The rationale for this study, however, stems from psilocybin’s interactio...
PsyPost
A recent study examined the role of patient expectations in influencing the outcomes of treatments with psilocybin, a psychedelic substance, compared to escitalopram, a widely prescribed antidepressant. Contrary to what some might expect, the study did not find a significant link between patients’ expectations and their actual responses to psilocybin therapy. However, the study also indicates that individuals who are more suggestible might experience a greater benefit from this treatment. The findings have been published in the journal Psychological Medicine. Depression’s staggering global imp...
PsyPost
In recent years, the scientific community has turned its attention back to the potential of psychedelics as therapeutic agents, with psilocybin, a naturally occurring substance found in certain mushrooms, at the forefront of this research. A new study published in the journal Molecular Psychiatry suggests possible benefits of using psilocybin-containing mushroom extract over its chemically synthesized counterpart for the treatment of psychiatric disorders such as depression, PTSD, obsessive-compulsive disorders, and anxiety. “My colleagues and I are very interested in the potential of psychede...
PsyPost
A recent study published in Scientific Reports reveals new insights into how psilocybin-assisted therapy modifies brain function in people with alcohol use disorder (AUD). These changes suggest a potential mechanism behind the therapy’s success and could point toward new avenues for treatment. Psilocybin is the psychoactive compound found in certain species of mushrooms, often referred to as “magic mushrooms,” known for its ability to produce profound changes in consciousness, perception, and mood. Psilocybin-assisted therapy combines the administration of psilocybin with psychological support...
PsyPost
Recent research conducted by teams from the Center for Psychedelic and Consciousness Research at Johns Hopkins School of Medicine and the Centre for Psychedelic Research at Imperial College London has taken a significant step forward in understanding the therapeutic mechanisms behind psilocybin therapy for treating major depressive disorder (MDD). Their study, published in the International Journal of Mental Health and Addiction, reveals that specific psychological experiences during psilocybin therapy, particularly mystical experiences and ego dissolution, play a critical role in the therapy’...
PsyPost
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら